FAKTOR OPTIONSSCHEIN - STRYKER CORP. Stock

Certificat

DE000PE2PSY2

Market Closed - Deutsche Boerse AG 03:50:26 2024-05-17 pm EDT
3.57 EUR -0.28% Intraday chart for FAKTOR OPTIONSSCHEIN - STRYKER CORP.
Current month-0.56%
1 month-0.83%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-17 3.57 -0.28%
24-05-16 3.58 -1.92%
24-05-15 3.65 -4.70%
24-05-14 3.83 -0.52%
24-05-13 3.85 +4.34%

Delayed Quote Deutsche Boerse AG

Last update May 17, 2024 at 03:50 pm EDT

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE2PSY
ISINDE000PE2PSY2
Date issued 2022-06-02
Strike 334 $
Maturity Unlimited
Parity 1 : 1
Emission price 10
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 14.7
Lowest since issue 2.98
Spread 0.07
Spread %1.92%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
334.7 USD
Average target price
372.4 USD
Spread / Average Target
+11.26%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW